[1] Roderburg C, Benz F, Vargas Cardenas D, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Inl, 2015, 35: 1172-1184.
[2] 马晓春. 应提高对脓毒症肝损伤的认识. 中华危重病急救医学, 2013, 25:198-200.
[3] Petrowsky H, Rana A, Kaldas F M, et al. Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg, 2014, 259: 1186-1194.
[4] 翁志雄, 余志金, 龙国清, 等. 脓毒症患者肝功能变化与病情严重度及预后的关系. 中国现代医生, 2013, 51: 31-33.
[5] 吴吟, 任建安. 氧化应激在脓毒症导致的肝损伤中的作用. 中国实用外科杂志, 2014, 34: 187-189.
[6] Cordoba J, Ventura-Cots M, Simón-Talero M, et al. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol, 2014, 60: 275-281.
[7] Nath B, Szabo G. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology, 2012, 55: 622-633.
[8] 赵伟, 何新飙. 脓毒症诱发急性肝功能障碍患者的危险因素和临床特征分析. 中华急诊医学杂志, 2012, 21: 61-64.
[9] Calkins K, Lowe A, Shew SB, et al. Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition. J Pediatr Surg, 2013, 48: 228-232.
[10] Sadamori H, Yagi T, Shinoura S, et al. Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg, 2013, 100: 122-129.
[11] 张剑, 楼天正, 张宁. 脓毒症的肝功能障碍发病机制及诊治研究. 中华急诊医学杂志, 2014, 23: 1183-1185.
[12] 张海霞, 吴先正, 杨长青, 等. 脓毒症患者肝功能损伤与病情严重程度及预后的相关性研究. 检验医学与临床, 2015, 12: 204-206.
[13] Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology, 2012, 55: 1551-1561.
[14] Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol, 2012, 57: 1336-1348. |
